semaglutide peptides for weight loss Semaglutide | Peak Biosciences

The results of cardiovascular and kidney outcomes trials involving sodiumglucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists, including assessment of subgroups, inform broader recommendations for cardiorenal protection in people with diabetes at high risk of cardiorenal disease

Uncover how GLP-1 and Ozempic impact diabetes and metabolic health with OnPoint Nutrition's expert guidance.

Concerned about Wegovy body odour

Women planning pregnancy on GLP-1 therapy need clear guidance on stopping timelines

Find out the causes behind this side effect, what to monitor, and when to seek medical advice for safety.

"GLP1s can radically change the way you eat, and many people end up falling short on protein, fiber, vitamins, and minerals